CN109010696A - 治疗前列腺增生的中药组合物及其制备方法 - Google Patents
治疗前列腺增生的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN109010696A CN109010696A CN201811118884.5A CN201811118884A CN109010696A CN 109010696 A CN109010696 A CN 109010696A CN 201811118884 A CN201811118884 A CN 201811118884A CN 109010696 A CN109010696 A CN 109010696A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- prostate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims description 7
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 16
- 244000183914 Dianthus superbus Species 0.000 claims abstract description 16
- 235000013535 Dianthus superbus Nutrition 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 241000594394 Hedyotis Species 0.000 claims abstract description 15
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 15
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 15
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 15
- 240000001398 Typha domingensis Species 0.000 claims abstract description 13
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 11
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 11
- 238000009835 boiling Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 21
- 235000014375 Curcuma Nutrition 0.000 abstract description 11
- 244000164480 Curcuma aromatica Species 0.000 abstract description 11
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract description 11
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract description 11
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract description 11
- 235000019509 white turmeric Nutrition 0.000 abstract description 11
- 231100000614 poison Toxicity 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000003440 toxic substance Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000002307 prostate Anatomy 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000011049 filling Methods 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 3
- 206010046555 Urinary retention Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010042170 Strangury Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000013583 drug formulation Substances 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229940100688 oral solution Drugs 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 244000134857 Typha capensis Species 0.000 description 1
- 208000028938 Urination disease Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000011279 abdominal lump Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229940083659 finasteride 1 mg Drugs 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940072254 proscar Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- VCKUSRYTPJJLNI-UHFFFAOYSA-N terazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 VCKUSRYTPJJLNI-UHFFFAOYSA-N 0.000 description 1
- 229960001693 terazosin Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960001712 testosterone propionate Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗前列腺增生的中药组合物,按质量份数计由黄芪1‑6份、当归2‑8份、玛卡2‑8份、淫羊藿2‑8份、牛膝1‑6份、莪术1‑6份、蒲黄1‑6份、瞿麦1‑6份、王不留行1‑6份、蛇舌草1‑6份和半枝莲1‑6份组成。本发明的中药组合物能够升降气机,调整人体阴阳平衡,使机体气血流畅,提高机体抗邪能力,从而使前列腺增生得到改善或治愈。通过各组分相互配伍,补气益肾,通淋化瘀,解毒行滞,以达治疗目的。
Description
技术领域
本发明属于中药技术领域,涉及一种治疗前列腺增生的中药组合物及其制备方法。
背景技术
前列腺增生症(Benign Prostatic Hyperp Lasia,BPH)是老年男性的常见疾病,中医属于“精癃”、“癃闭”范畴,此病多呈慢性起病,增生的前列腺挤压尿道,导致一系列排尿障碍症状,如尿频尿急、尿流细弱、尿不尽等排尿障碍,患者常因急性尿潴留而到医院就诊。目前,治疗前列腺增生症的药物品种繁多,西医常用保列治、特拉唑嗪治疗,临床多采用中西医结合的方法提高疗效。但它们都有各自的局限性。如果只采用通淋利尿或是补肾壮阳药物,则是标本不得,效果不佳。且一般药物治疗对急性尿潴留一时难奏效。如果采用手术摘除前列腺后问题更复杂,可能给患者带来一定的损害和并发症。因此,本病经药物治疗、手术治疗后复发者多见。且低收入病人常因疗程长费用高而难以坚持。
据报道,男性40岁以上发病率超过30%,发病率随年龄的增加而增加,50岁以上约50%,80~90岁可达80%以上,我国庞大的前列腺增生患者人群以及高昂的医疗费用已经成为一种社会问题。
发明内容
有鉴于此,本发明的目的在于提供一种安全、经济、无毒副作用的治疗前列腺增生的中药组合物及其制备方法。
为达到上述目的,本发明提供如下技术方案:
1.治疗前列腺增生的中药组合物,按质量份数计,由以下成分组成:黄芪1-6份、当归2-8份、玛卡2-8份、淫羊藿2-8份、牛膝1-6份、莪术1-6份、蒲黄1-6份、瞿麦1-6份、王不留行1-6份、蛇舌草1-6份和半枝莲1-6份。
进一步,所述中药组合物按质量份数计,由以下成分组成:黄芪2-5份、当归4-8份、玛卡4-8份、淫羊藿4-8份、牛膝2-6份、莪术2-6份、蒲黄2-6份、瞿麦2-6份、王不留行2-5份、蛇舌草2-5份和半枝莲2-5份。
进一步,所述中药组合物按质量份数计,由以下成分组成:黄芪3-4份、当归4-6份、玛卡6-8份、淫羊藿6-8份、牛膝4-6份、莪术4-6份、蒲黄4-6份、瞿麦4-6份、王不留行3-5份、蛇舌草3-5份和半枝莲3-5份。
进一步,所述中药组合物按质量份数计,由以下成分组成:黄芪4份、当归4份、玛卡8份、淫羊藿8份、牛膝4份、莪术4份、蒲黄4份、瞿麦4份、王不留行5份、蛇舌草5份和半枝莲5份。
2.以上任一项所述的中药组合物的制备方法,将所有组分混合后加1.3-2倍体积的水浸泡0.5-1.5小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
进一步,将所有组分混合后加1.5倍体积的水浸泡1小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
除了水煎服,还可以通过常规的药物制剂方法将所述中药组合物制备成口服液、颗粒冲剂或胶囊。
各中药的药理作用:
黄芪:甘,微温。归肺、脾经。功效与主治:补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
当归:甘、辛,温。归肝、心、脾经。功效与主治:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。
玛卡:辛、甘、温、无毒。归肾、肝、脾经。功效与主治:温肾壮阳,强筋壮骨,散寒、止痛、调血脉。
淫羊藿:辛、甘,温。归肝、肾经。功效与主治:补肾阳,强筋骨,祛风湿。用于肾阳虚衰,阳痿遗精,筋骨痿软,风湿痹痛,麻木拘挛。
牛膝:苦、甘、酸,平。归肝、肾经。功效与主治:逐瘀通经,补肝肾,强筋骨,利尿通淋,引血下行。用于经闭,痛经,腰膝酸痛,筋骨无力,淋证,水肿,头痛,眩晕,牙痛,口疮,吐血,衄血。
莪术:辛、苦,温。归肝、脾经。功效与主治:行气破血,消积止痛。用于癥瘕痞块,瘀血经闭,胸痹心痛,食积胀痛。
蒲黄:甘,平。归肝、心包经。功效与主治:止血,化瘀,通淋。用于吐血,衄血,咯血,崩漏,外伤出血,经闭痛经,胸腹刺痛,跌扑肿痛,血淋涩痛。
瞿麦:苦,寒。归心、小肠经。功效与主治:利尿通淋,活血通经。用于热淋,血淋,石淋,小便不通,淋沥涩痛,经闭瘀阻。
王不留行:苦,平。归肝、胃经。功效与主治:活血通经,下乳消肿,利尿通淋。用于经闭,痛经,乳汁不下,乳痈肿痛,淋证涩痛。
蛇舌草:甘、淡,凉。归胃、肺肠、膀胱经。功能主治清热解毒,利尿消肿,活血止痛。用于肠痈(阑尾炎),疮疖肿毒,湿热黄疸,小便不利等症;外用治疮疖痈肿,毒蛇咬伤。
半枝莲:辛、苦,寒。归肺、肝、肾经。功效与主治:清热解毒,化瘀利尿。用于疔疮肿毒,咽喉肿痛,跌扑伤痛,水肿,黄疸,蛇虫咬伤。
中医认为,前列腺增生的基本病因是肾元亏虚,其基本病机则责之于肾虚血瘀。年老体衰、肾气亏虚是前列腺增生症的发病基础,瘀血、痰浊、湿热是基本的病理因素;本虚标实是基本病机特点:以肾气亏虚为本,瘀血、痰浊聚结为标,血瘀贯穿于病程始终,是前列腺腺体增生病理改变的关键环节,瘀是其中最重要的病因和病理产物。根据气虚血瘀并重、虚实夹杂的病机特点,治疗以通淋化瘀,行气活血中药为主。
本发明的有益效果在于:本发明从病因病机上抓住了前列腺增生是肾气虚导致的前列腺瘀滞,补肾气是治本,化瘀通淋是治标。本发明通过合理配伍,能够升降气机,调整人体阴阳平衡,使机体气血流畅,提高机体抗邪能力,从而使前列腺增生得到抑制和消失。
本发明的中药组合物以黄芪、玛卡、当归、淫羊藿为君药,补气益肾,益气扶正以补其虚。黄芪甘温、入脾肺经,补中益气、升清降浊、为补气要药,并可消散血瘀。以淫羊藿、玛卡补肾壮阳,强筋壮骨。以当归补血活血;以莪术、蒲黄、瞿麦和王不留行为臣药,通淋化瘀,行气活血,以莪术行气活血,蒲黄祛瘀通淋,瞿麦、王不留行利尿通淋,君臣二药为伍互补;以蛇舌草、半枝莲为佐解毒行瘀;以牛膝为使活血、引药下行使药物作用于病所。本发明的中药组合物通过各成分相互配伍,共凑益气、活血、散结、利湿等功效,以达治疗目的。安全无毒副作用,使用本发明治疗前列腺增生效果显著且费用少。避免了手术治疗的高风险和高费用,也解决了中药治疗经久不愈的问题。目前治疗前列腺增生症的药物品种繁多,且都有不错的疗效,但它们都有各自的局限性。而本发明在补肾益气的同时,更针对湿热及瘀血阻塞尿路的病因,从而减轻前列腺因充血所致的肿大,尿道受压所致的排尿困难,改善患者的生活质量,达到标本同治的效果,且无明显不良反应,在前列腺增生领域有广阔的临床应用前景。
具体实施方式
下面对本发明的优选实施例进行详细的描述。实施例中未注明具体条件的实验方法,通常按照常规条件或按照制造厂商所建议的条件。
实施例1
一种治疗前列腺增生的中药组合物,按每日用量由以下组分组成:
黄芪12g、当归12g、玛卡24g、淫羊藿24g、牛膝12g、莪术12g、蒲黄12g、瞿麦12g、王不留行15g、蛇舌草15g和半枝莲15g。
将上述中药材粉碎后用50%乙醇溶液热回流提取2次(1h/次),料液比1:20,抽滤后合并滤液,再减压浓缩至1/5-1/10。
实施例2
一种治疗前列腺增生的中药组合物,由以下组分组成:
黄芪16g、当归16g、玛卡20g、淫羊藿20g、牛膝20g、莪术20g、蒲黄20g、瞿麦20g、王不留行16g、蛇舌草16g和半枝莲16g。
将所有混合后加1.3-2倍体积的水浸泡0.5-1.5小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可,上述药方为一日一剂,药汁均分早晚服用。
将上述中药材粉碎后用水萃取有效成分,通过常规的药物制剂方法将所述中药组合物制备成口服液、颗粒冲剂或胶囊。
实施例3
一种治疗前列腺增生的中药组合物,按质量份数计由以下组分组成:
黄芪12g、当归20g、玛卡24g、淫羊藿24g、牛膝20g、莪术20g、蒲黄12g、瞿麦12g、王不留行12g、蛇舌草12g和半枝莲12g。
实施例4
一种治疗前列腺增生的中药组合物,按质量份数计由以下组分组成:
黄芪9g、当归18g、玛卡24g、淫羊藿24g、牛膝12g、莪术12g、蒲黄15g、瞿麦15g、王不留行15g、蛇舌草15g和半枝莲15g。
实施例5
雄性SPF级SD大鼠,60只,体重200~250g,笼内饲养,正常采光,自由饮食饮水。随机分为正常组,模型组,中药复方高剂量组、中药复方低剂量组和阳性对照组。将大鼠麻醉后75%酒精消毒,经阴囊摘除双侧睾丸,残端处结扎确保止血,缝合皮肤后肌肉注射青霉素20万U/只,连续3天。1周后,除正常组外,其余大鼠每天皮下注射丙酸睾丸酮0.5mg/0.02mL,一天一次,连续15天;注射针头需保证无菌、无水,并同时分别灌胃给药;正常组和模型组以生理盐水0.5mL/100g体重灌胃;取实施例1所制备的中药组合物提取物,按中药复方高剂量组给予500mg/(kg·d)灌胃,中药复方低剂量组给予150mg/(kg·d)灌胃,阳性对照组灌胃非那雄胺1mg/(kg·d),连续用药30天。
最后一次给药8小时后,再禁食12h,称取各组大鼠质量,脱颈椎处死后解剖腹腔,下腔静脉取血,分离血清,用酶联免疫方法测定大鼠血清中二氢睾酮、睾酮和雌二醇水平,测定结果如表1所示。再分离出大鼠前列腺,用分析天平称重,计算前列腺指数=前列腺湿质量(mg)/体质量(g),其数值越大前列腺增生情况越严重,测定结果如表2所示。
表1各组大鼠血清激素水平变化
与模型组比较,*P<0.05
与模型组相比,中药复方高剂量组、中药复方低剂量组、阳性对照组的大鼠血清中的二氢睾酮的含量均有显著下降(P<0.05),且中药复方高剂量组的睾酮、睾酮/雌二醇值亦有明显下降(P<0.05)。
表2中药组合物提取物对大鼠前列腺指数的影响
与模型组比较,*P<0.05
由表2可知,大鼠前列腺增生模型造模成功,阳性对照组和中药复方组均显著降低增生前列腺的质量,P<0.05。说明本发明的中药组合物能限制降低或抑制前列腺增生。
最后说明的是,以上优选实施例仅用以说明本发明的技术方案而非限制,尽管通过上述优选实施例已经对本发明进行了详细的描述,但本领域技术人员应当理解,可以在形式上和细节上对其作出各种各样的改变,而不偏离本发明权利要求书所限定的范围。
Claims (6)
1.治疗前列腺增生的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪1-6份、当归2-8份、玛卡2-8份、淫羊藿2-8份、牛膝1-6份、莪术1-6份、蒲黄1-6份、瞿麦1-6份、王不留行1-6份、蛇舌草1-6份和半枝莲1-6份。
2.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪2-5份、当归4-8份、玛卡4-8份、淫羊藿4-8份、牛膝2-6份、莪术2-6份、蒲黄2-6份、瞿麦2-6份、王不留行2-5份、蛇舌草2-5份和半枝莲2-5份。
3.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪3-4份、当归4-6份、玛卡6-8份、淫羊藿6-8份、牛膝4-6份、莪术4-6份、蒲黄4-6份、瞿麦4-6份、王不留行3-5份、蛇舌草3-5份和半枝莲3-5份。
4.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物按质量份数计,由以下成分组成:黄芪4份、当归4份、玛卡8份、淫羊藿8份、牛膝4份、莪术4份、蒲黄4份、瞿麦4份、王不留行5份、蛇舌草5份和半枝莲5份。
5.权利要求1-4任一项所述的中药组合物的制备方法,其特征在于,将所有药材组分混合后加1.3-2倍体积的水浸泡0.5-1.5小时,用文火煎熬20-40分钟,过滤出药汁备用;
药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
6.根据权利要求5所述的制备方法,其特征在于,将所有药材组分混合后加1.5倍体积的水浸泡1小时,用文火煎熬20-40分钟,过滤出药汁备用;药渣里再加1倍体积的水煮沸后文火煎熬20-30分钟,过滤出药汁,合并两次的药汁即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811118884.5A CN109010696A (zh) | 2018-09-25 | 2018-09-25 | 治疗前列腺增生的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811118884.5A CN109010696A (zh) | 2018-09-25 | 2018-09-25 | 治疗前列腺增生的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109010696A true CN109010696A (zh) | 2018-12-18 |
Family
ID=64618229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811118884.5A Withdrawn CN109010696A (zh) | 2018-09-25 | 2018-09-25 | 治疗前列腺增生的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109010696A (zh) |
-
2018
- 2018-09-25 CN CN201811118884.5A patent/CN109010696A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102166317B (zh) | 一种治疗崩漏的中药组合物 | |
CN105327205A (zh) | 一种治疗甲状腺癌的中药制剂 | |
CN101757591B (zh) | 一种治疗慢性结肠炎、直肠炎的中药组合物 | |
CN102772712B (zh) | 一种治疗热毒炽盛血瘀型糖尿病足的中药组合物 | |
CN106728863A (zh) | 一种治疗糖尿病的中药及其制备方法 | |
CN101607067B (zh) | 一种治疗胆结石的中药制剂及制备方法 | |
CN103341010A (zh) | 一种治疗黄疸型肝炎的中药制剂及制备方法 | |
CN103212020B (zh) | 一种治疗功能性消化不良的中药组合物 | |
CN104784245A (zh) | 一种治疗宫颈癌的药物 | |
CN104706919B (zh) | 一种治疗体表溃疡的药物组合物 | |
CN109010696A (zh) | 治疗前列腺增生的中药组合物及其制备方法 | |
CN105770691A (zh) | 一种用于治疗宫颈癌的药物制剂及其用途 | |
CN102038889B (zh) | 治疗风湿性心脏病的中药 | |
CN105168946A (zh) | 一种治疗糖尿病的中药组合物及其用途 | |
CN105031505A (zh) | 一种治疗良性前列腺增生肥大的药物及其制备方法 | |
CN109602838A (zh) | 一种治疗慢性炎症的中药组合物及其制备方法和应用 | |
CN104225016A (zh) | 一种治疗脾胃虚弱型慢性萎缩性胃炎的药物组合物 | |
CN107961355A (zh) | 一种治疗肝腹水的肚脐丸及其制备方法 | |
CN103301374B (zh) | 一种治疗产后非特异性阴道炎的药物组合物 | |
CN105999196A (zh) | 一种用于治疗急性腹膜炎的中药制剂及制备方法 | |
CN105381273A (zh) | 一种治疗糖尿病的药物组合物及其用途 | |
CN104758421A (zh) | 一种治疗肝气郁结症慢性前列腺炎的艾可合剂及制备方法 | |
CN105327299A (zh) | 一种用于治疗原发性血小板减少紫癜的药物 | |
CN105709005A (zh) | 一种乳康丸 | |
CN106266970B (zh) | 一种治疗生产引发子宫内膜炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181218 |
|
WW01 | Invention patent application withdrawn after publication |